Dr. Gunda Georg is featured in a Masonic Cancer Center Article which discusses Minnelide, an investigational drug for pancreatic cancer patients. Minnelide is now entering a Phase IA clinical trial at the University of Minnesota.
Read the full story here: https://give.umn.edu/stories/curtain
